F
Fernando P. Polack
Researcher at Vanderbilt University
Publications - 142
Citations - 20176
Fernando P. Polack is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Virus & Measles virus. The author has an hindex of 40, co-authored 125 publications receiving 11647 citations. Previous affiliations of Fernando P. Polack include Vanderbilt University Medical Center & University of the Witwatersrand.
Papers
More filters
Journal ArticleDOI
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P. Polack,Stephen J. Thomas,Nicholas Kitchin,Judith Absalon,Alejandra Gurtman,Stephen Lockhart,John L. Perez,Gonzalo Pérez Marc,Edson D. Moreira,Cristiano Zerbini,Ruth Bailey,Kena A. Swanson,Satrajit Roychoudhury,Kenneth Koury,Ping Li,Warren Kalina,David A. Cooper,Robert W. Frenck,Laura L. Hammitt,Özlem Türeci,Haylene Nell,Axel Schaefer,Serhat Ünal,Dina B. Tresnan,Susan Mather,Philip R. Dormitzer,Ugur Sahin,Kathrin U. Jansen,William C. Gruber +28 more
TL;DR: A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older and safety over a median of 2 months was similar to that of other viral vaccines.
Journal ArticleDOI
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
Ting Shi,David A. McAllister,Katherine L. O'Brien,Eric A. F. Simões,Shabir A. Madhi,Bradford D. Gessner,Fernando P. Polack,Evelyn Balsells,Sozinho Acácio,Claudia Aguayo,Issifou Alassani,Asad Ali,Martin Antonio,Shally Awasthi,Juliet O. Awori,Eduardo Azziz-Baumgartner,Eduardo Azziz-Baumgartner,Henry C. Baggett,Vicky L. Baillie,Angel Balmaseda,Alfredo Barahona,Sudha Basnet,Sudha Basnet,Quique Bassat,Quique Bassat,Wilma Basualdo,Godfrey Bigogo,Louis Bont,Robert F. Breiman,W. Abdullah Brooks,W. Abdullah Brooks,Shobha Broor,Nigel Bruce,Dana Bruden,Philippe Buchy,Stuart Campbell,Phyllis Carosone-Link,Mandeep S. Chadha,James Chipeta,Monidarin Chou,Wilfrido Clara,Cheryl Cohen,Cheryl Cohen,Elizabeth de Cuellar,Duc Anh Dang,Budragchaagiin Dash-Yandag,Maria Deloria-Knoll,Mukesh Dherani,Tekchheng Eap,Bernard E. Ebruke,Marcela Echavarria,Carla Cecília de Freitas Lázaro Emediato,Rodrigo Fasce,Daniel R. Feikin,Luzhao Feng,Angela Gentile,Aubree Gordon,Doli Goswami,Doli Goswami,Sophie Goyet,Michelle J. Groome,Natasha B. Halasa,Siddhivinayak Hirve,Nusrat Homaira,Nusrat Homaira,Stephen R. C. Howie,Stephen R. C. Howie,Stephen R. C. Howie,Jorge Jara,Imane Jroundi,Cissy B. Kartasasmita,Najwa Khuri-Bulos,Karen L. Kotloff,Anand Krishnan,Romina Libster,Romina Libster,Olga Lopez,Marilla G. Lucero,Florencia Lución,Socorro Lupisan,Debora N. Marcone,John P. McCracken,Mario Mejia,Jennifer C. Moïsi,Joel M. Montgomery,David P. Moore,Cinta Moraleda,Jocelyn Moyes,Jocelyn Moyes,Patrick K. Munywoki,Patrick K. Munywoki,Kuswandewi Mutyara,Mark P. Nicol,D. James Nokes,D. James Nokes,Pagbajabyn Nymadawa,Maria Tereza da Costa Oliveira,Histoshi Oshitani,Nitin Pandey,Gláucia Paranhos-Baccalà,Lia Neu Phillips,Valentina Picot,Mustafizur Rahman,Mala Rakoto-Andrianarivelo,Zeba A Rasmussen,Barbara Rath,Annick Robinson,Candice Romero,Graciela Russomando,Vahid Salimi,Pongpun Sawatwong,Nienke M Scheltema,Brunhilde Schweiger,J. Anthony G. Scott,J. Anthony G. Scott,Phil Seidenberg,Kunling Shen,Rosalyn J. Singleton,Rosalyn J. Singleton,Viviana Sotomayor,Tor A. Strand,Tor A. Strand,Agustinus Sutanto,Mariam Sylla,Milagritos D. Tapia,Somsak Thamthitiwat,Elizabeth Thomas,Rafal Tokarz,Claudia Turner,Marietjie Venter,Sunthareeya Waicharoen,Jianwei Wang,Wanitda Watthanaworawit,Lay-Myint Yoshida,Hongjie Yu,Heather J. Zar,Harry Campbell,Harish Nair,Harish Nair +138 more
TL;DR: In this paper, the authors estimated the incidence and hospital admission rate of RSV-associated acute lower respiratory infection (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions.
Journal ArticleDOI
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
Romina Libster,Gonzalo Pérez Marc,Diego Wappner,Silvina Coviello,Alejandra Bianchi,Virginia Braem,Ignacio Esteban,Mauricio T. Caballero,Cristian Wood,Mabel Berrueta,Anibal Rondan,Gabriela Lescano,Pablo Cruz,Yvonne Ritou,Valeria Fernandez Vina,Damian Alvarez Paggi,Sebastian Esperante,Adrián Ferreti,Gaston Ofman,Alvaro Ciganda,Rocio Rodriguez,Jorge Lantos,Ricardo Valentini,Nicolas Itcovici,Alejandra Hintze,M Laura Oyarvide,Candela Etchegaray,Alejandra Neira,Ivonne Name,Julieta Alfonso,Rocio Lopez Castelo,Gisela Caruso,Sofia Rapelius,Fernando Alvez,Federico Cesar Etchenique,Federico Dimase,Dario Raul Alvarez,Sofia Sol Aranda,Clara Sanchez Yanotti,Julian De Luca,Sofia Jares Baglivo,Sofia Lujan Laudanno,Florencia Nowogrodzki,Ramiro Manuel Larrea,Maria Dolores Silveyra,Gabriel Leberzstein,Alejandra Debonis,Juan Molinos,Miguel Santiago Gonzalez,Eduardo Perez,Nicolás Kreplak,Susana Pastor Arguello,Luz Gibbons,Fernando Althabe,Eduardo Bergel,Fernando P. Polack +55 more
TL;DR: In this paper, a randomized, double-blind, placebo-controlled trial of convalescent plasma with high IgG titers against SARS-CoV-2 in older adult patients within 72 hours after the onset of mild Covid-19 symptoms was conducted.
Journal ArticleDOI
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.
Stella G. Muthuri,Sudhir Venkatesan,Puja R. Myles,Jo Leonardi-Bee,Tarig Saleh Al Khuwaitir,Adbullah Al Mamun,Ashish P Anovadiya,Eduardo Azziz-Baumgartner,Clarisa Báez,Matteo Bassetti,Bojana Beović,Barbara Bertisch,Isabelle Bonmarin,Robert Booy,Víctor Hugo Borja-Aburto,Heinz Burgmann,Bin Cao,Jordi Carratalà,Justin T Denholm,Samuel R. Dominguez,Péricles Almeida Delfino Duarte,Gal Dubnov-Raz,Marcela Echavarria,Sergio Fanella,Zhancheng Gao,Patrick Gérardin,Maddalena Giannella,Sophie Gubbels,Jethro Herberg,A. Iglesias,Peter Höger,Xiaoyun Hu,Quazi Tarikul Islam,Mirela Foresti Jiménez,Amr Kandeel,Gerben Keijzers,Hossein Khalili,Marian Knight,Koichiro Kudo,Gabriela Kusznierz,Ilija Kuzman,Arthur M C Kwan,Idriss Lahlou Amine,Eduard Langenegger,Kamran Bagheri Lankarani,Yee-Sin Leo,Rita Linko,Pei Liu,Faris Madanat,Elga Mayo-Montero,Allison McGeer,Ziad A. Memish,Gökhan Metan,Auksė Mickiene,Dragan Mikić,Kristin G.-I. Mohn,Kristin G.-I. Mohn,Ahmadreza Moradi,Ahmadreza Moradi,Pagbajabyn Nymadawa,Maria E. Oliva,Mehpare Ozkan,Dhruv Parekh,Mical Paul,Fernando P. Polack,Barbara Rath,Alejandro Rodríguez,Elena B. Sarrouf,Anna C. Seale,Anna C. Seale,Bunyamin Sertogullarindan,Marilda M. Siqueira,Joanna Skręt-Magierło,Frank P. Stephan,Ewa Talarek,Julian W. Tang,Julian W. Tang,Kelvin K. W. To,Antoni Torres,Selda Hançerli Törün,Dat Tran,Timothy M. Uyeki,Annelies van Zwol,Wendy Vaudry,Tjasa Vidmar,Renata T. C. Yokota,Paul Zarogoulidis,Jonathan S. Nguyen-Van-Tam +87 more
TL;DR: There was an increase in the mortality hazard rate with each day's delay in initiation of treatment up to day 5 as compared with treatment initiated within 2 days of symptom onset, and early treatment versus no treatment was also associated with a reduction in mortality risk.
Journal ArticleDOI
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado,Silvina Coviello,A. Clara Monsalvo,Guillermina A. Melendi,Johanna Zea Hernandez,Juan P. Batalle,Leandro Diaz,Alfonsina Trento,Herng Yu Chang,Wayne Mitzner,Jeffrey V. Ravetch,José A. Melero,Pablo M. Irusta,Fernando P. Polack +13 more
TL;DR: It is shown that inactivated RSV vaccines may be rendered safe and effective by inclusion of TLR agonists in their formulation, and affinity maturation is identified as a key factor for the safe immunization of infants.